Evidence map›Paper›PMID 30333719›Full record

ArticleFrontiers in neuroscience2018

Inmaculada C Rodríguez-Rojo, Pablo Cuesta, María Eugenia López, Jaisalmer de Frutos-Lucas, Ricardo Bruña, Ernesto Pereda, Ana Barabash, Pedro Montejo, Mercedes Montenegro-Peña, Alberto Marcos and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Genetic polymorphisms iniScience · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Inmaculada C Rodríguez-RojoLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Pablo CuestaLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
María Eugenia LópezLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Jaisalmer de Frutos-LucasLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Ricardo BruñaLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Ernesto PeredaLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Ana BarabashLaboratory of Psychoneuroendocrinology and Genetics, Hospital Clínico San Carlos, Madrid, Spain.
Pedro MontejoCenter for the Prevention of Cognitive Impairment, Public Health Institute, Madrid-Salud, Madrid, Spain.
Mercedes Montenegro-PeñaCenter for the Prevention of Cognitive Impairment, Public Health Institute, Madrid-Salud, Madrid, Spain.
Alberto MarcosNeurology Department, Hospital Clínico San Carlos, Madrid, Spain.
Ramón López-HigesDepartment of Experimental Psychology, Cognitive Processes and Speech Therapy, Universidad Complutense de Madrid, Madrid, Spain.
Alberto FernándezLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Fernando MaestúLaboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain.
Universidad Politécnica de Madrid · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESUniversidad Complutense de Madrid · ESHospital Clínico San Carlos · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESUniversidad Autónoma de Madrid · ESUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathophysiological processes undermining brain functioning decades before the onset of the clinical symptoms associated with dementia are still not well understood. Several heritability studies have reported that the Brain Derived Neurotrophic Factor (

Indexed as

Alzheimer's diseaseBDNF Val66Metcognitive functioninggamma rhythmshealthy agingmagnetoencephalography

Identifiers

PMID30333719
PMCPMC6176075
OpenAlexW2894608052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.